【大清生物Datsing是哪个国家的品牌？】

英文翻译：Beijing Daqing Biotechnology Co., Ltd. is located in the core area of Zhongguancun Science and technology park. Founded in 2001, it is a high-tech enterprise founded by returned overseas students. It is mainly engaged in the research and development, production, sales and service of biomedical materials, regenerative medicine and tissue engineering, stem cells and biological treatment products. It is the earliest in China to carry out regenerative medicine, tissue engineering and biological treatment One of the enterprises promoting the industrialization of medical material products. At the end of 2012, Beijing Shuimu venture capital center was introduced as the strategic shareholder, and at the beginning of 2014, Beijing Aurora Borealis and Tianjin Haida venture capital company were introduced. In 2006, Daqing biology and West China Hospital of Sichuan University reached a strategic partnership in the research and product development of biomedical materials. At the same time, relying on the technical advantages of the Institute of life science and medicine, the Institute of materials science and engineering, the Department of chemical engineering and many research institutions of Tsinghua University, integrating advanced technologies and resources at home and abroad, we have made many breakthroughs in the industrialization of related technologies. At present, there are eight products of Daqing biology that have obtained CFDA medical device product registration, which are: new generation high-tech product absorbable hemostasis film (Daqing biological paper), artificial skin gene transfected pig skin (skin sticking), allogeneic bone repair material (Bayer gold), allogeneic tendon repair material (Bayer tendon), biological hernia repair sheet (ribeisen), I dental implant , bone repair materials (zhiguling) and tooth desensitizer (aominqing). At present, the company still has 5 products in the national designated clinical trial base to carry out clinical research or have completed clinical research, and several series of products are under development. Daqing biology obtained the class III medical device production license in 2003 and passed the quality system assessment of medical device manufacturers in 2005. In 2007, it passed iso9001-iso13485 international quality system certification. In 2008, it obtained the national stomatological material and medical device business license. In 2016, the tooth desensitizer product passed the EU CE certification, and the absorbable haemostatic film product passed the CE system certification. The company has invested and built more than 4000 square meters of advanced modern production plant in Changping Science and technology park. In addition to producing class II and III implanted medical devices, it has also built cell culture room, cell and scaffold composite product workshop. In order to meet the development needs of the enterprise and improve the core competitiveness of the enterprise, the company has invested and built a large-scale R & D center in Zhongguancun medical engineering transformation center, which has more than 20 R & D personnel, including 2 doctors, 10 masters and 3 senior engineers, and has initially formed a research and development team with multiple disciplines complementing each other organically and reasonable professional collocation. In 2012, the company acquired Chongqing Zongshen Junhui Biotechnology Co., Ltd. (now renamed Chongqing daqingyicheng Biotechnology Co., Ltd.) and Chongqing Zongshen Yida Biotechnology R & D Co., Ltd. (now renamed Chongqing daqingyida Biotechnology Co., Ltd.). Chongqing subsidiary is a high-tech enterprise specializing in the production of biomedical materials and a typical "production, learning and research" The main product of the company is gene transfected pig skin. In March 2016, the company acquired Beijing SiGe Oriental Medical Electronic Technology Co., Ltd. (now renamed Beijing Daqing SiGe Technology Co., Ltd.). Xige company is a supplier focusing on digital oral products and services. At present, the company's main products are no. I implant, tooth desensitizer (aominqing), bone powder (baioujin), etc. In September 2016, Tianjin Zhongjin Biological Development Co., Ltd. was acquired. Zhongjin company is one of the earliest manufacturers of bone active repair materials in China. Its main product bone repair materials (bone graft) is a national patent product. Daqing biology has more than 300 high-tech talents composed of experts, professors, doctors and masters. Through the establishment of a scientific human resources assessment system, the establishment of employee stock holding platform, the establishment and implementation of ERP information management system, the company has established a people-oriented talent concept and built an excellent corporate culture. The company pays attention to the cultivation of employees' ability and quality. In order to improve the management ability of the core team, in 2013 and 2016, it cooperated with Guanghua School of management, Peking University, and specially set up the first and second classes of EMBA advanced studies.

本文链接： https://www.waitui.com/brand/eddd09692.html 联系电话：010-62967988,62988617